In contrast, after exogenous IGFL2‐AS1 overexpression, the viability of CRC cells was considerably increased (Figure 3B) and proliferation was enhanced (Figure 3C, D) compared with those of control cells. This evidence concerns the gene IGFL2 and colorectal carcinoma.